HealthPrize CEO Tom Kottler recently spoke with Jill Malandrino, host of Nasdaq’s Trade Talks, about why pharma should look to medication adherence as its new profit source.
About Vishal Khanna
This author has yet to write their bio.Meanwhile lets just say that we are proud Vishal Khanna contributed a whooping 21 entries.
Entries by Vishal Khanna
Pharma’s continued dependence on tactics such as raising drug prices to hit profit targets just aren’t sustainable long-term. Further, price increases – responsible for 100 percent of pharma’s 2016 earnings per share (EPS) growth – do not improve patient outcomes or save lives.
Boehringer Ingelheim and HealthPrize Technologies today announced the expansion of the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim medicines, including select medicines available in the Respimat inhaler.
The digital adherence and patient engagement platform is recognized by Frost for improving patient outcomes and solving business challenges.
The two companies extend their collaboration to integrate West’s drug delivery systems with HealthPrize’s digital adherence and engagement platform.
We’re packing our bags – and our booth shwag – and getting ready for the Spring season of life science marketing conferences. If you’d like to learn more about HealthPrize, we’d like to learn more about your challenges and goals.
Medication non-adherence is one of the most serious problems in healthcare, posing a heavy financial impact on all constituencies.
The pharmaceutical services leader will help guide the company’s growth and expansion in the life sciences industry
Former inVentiv executive brings key pharmaceutical services sector experience to HealthPrize’s board.
The ZS Associates principal will bring her expansive patient engagement and multi-channel marketing experience to HealthPrize’s board